author-photo

Richard G. Hahn

Mayo Clinic

142

Papers

7275

Citations

Citation Trend

Filter By

Papers (112) Sort By

Journal Conference Others

Tuberculosis in the Household1,2

2019 American review of tuberculosis
- Richard G. Hahn
Show All
- Source
- Cite
- Save
Citations (0)
A Survey of Persons Exposed to Tuberculosis in the Household11,2

2019 American review of tuberculosis
Show All
- Source
- Cite
- Save
Citations (0)
Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282

2006 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (33)
Phase II study of α2 interferon in the treatment of the chronic myeloproliferative disorders (E5487)

2003 Cancer
Show All
- Source
- Cite
- Save
Citations (45)
Phase II trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282

2001 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (166)
Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study.

1995 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (35)
Phase III study comparing vincristine, doxorubicin (Adriamycin), and dexamethasone (VAD) chemotherapy with VAD plus recombinant interferon alfa-2 in refractory or relapsed multiple myeloma. An Eastern Cooperative Oncology Group study.

1995 American Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (38)
Neoadjuvant chemotherapy for invasive bladder carcinoma: disease outcome and bladder preservation and relationship to local tumor response.

1994 European Urology
Show All
- Source
- Cite
- Save
Citations (11)
Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an Eastern Cooperative Oncology Group trial.

1994 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (95)
A VM 26-based regimen for patients with previously untreated non-Hodgkin lymphoma. Prolonged disease-free survival in patients younger than 60 years of age: a phase II trial of the eastern Cooperative Oncology Group.

1993 Cancer
Show All
- Source
- Cite
- Save
Citations (3)